Comparison of a Three-Component Acellular Pertussis Vaccine With a Whole-Cell Pertussis Vaccine in 4- Through 6-Year-Old Children

This publication has 9 references indexed in Scilit:

• Pertussis Antibodies, Protection, and Vaccine Efficacy After Household Exposure
  Archives of Pediatrics & Adolescent Medicine, 1992
• Differences in Reactogenicity and Antigenicity of Acellular and Standard Pertussis Vaccines Combined with Diphtheria and Tetanus in Infants
  The Journal of Infectious Diseases, 1988
• Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children
  The Pediatric Infectious Disease Journal, 1987
• Diphtheria, Tetanus, and Pertussis Vaccine
  American Journal of Diseases of Children, 1986
• A Double-blind Study Comparing an Acellular Pertussis—Component DTP Vaccine With a Whole-Cell Pertussis—Component DTP Vaccine in 18-Month-Old Children
  Archives of Pediatrics & Adolescent Medicine, 1986
• Neutralizing Antibodies to Pertussis Toxin in Whooping Cough
  The Journal of Infectious Diseases, 1985
• The concept of pertussis as a toxin-mediated disease
  The Pediatric Infectious Disease Journal, 1984
• Pertussis Toxin and Extracytoplasmic Adenylate Cyclase as Virulence Factors of Bordetella pertussis
  The Journal of Infectious Diseases, 1984
• DEVELOPMENT OF A PERTUSSIS COMPONENT VACCINE IN JAPAN
  The Lancet, 1984